Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma

NCT03307759 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Slow patient accrual

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Pembrolizumab
RADIATION: Radiotherapy (SABR)

Sponsor

Peter MacCallum Cancer Centre, Australia